Litcius/Paper detail

Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting

Luca Navarini, Luisa Costa, Marco Tasso, Maria Sole Chimenti, Damiano Currado, Giulia Lavinia Fonti, Massimo Ciccozzi, Domenico Paolo Emanuele Margiotta, Carolina Benigno, Erica De Martino, Roberto Perricone, Antonella Afeltra, Raffaele Scarpa, Francesco Caso

2020Clinical Rheumatology32 citationsDOI

Topics & Concepts

MedicineDiscontinuationPsoriatic arthritisInternal medicineRetention rateProportional hazards modelAdverse effectUstekinumabRetrospective cohort studyRheumatoid arthritisTNF inhibitorRheumatologyEtanerceptAdalimumabComputer scienceComputer securitySpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and Pathogenesis